Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids - PubMed (original) (raw)
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids
B Yu et al. J Clin Invest. 1997.
Abstract
Lipopolysaccharide binding protein (LBP) is a plasma protein known to facilitate the diffusion of bacterial LPS (endotoxin). LBP catalyzes movement of LPS monomers from LPS aggregates to HDL particles, to phospholipid bilayers, and to a binding site on a second plasma protein, soluble CD14 (sCD14). sCD14 can hasten transfer by receiving an LPS monomer from an LPS aggregate, and then surrendering it to an HDL particle, thus acting as a soluble "shuttle" for an insoluble lipid. Here we show that LBP and sCD14 shuttle not only LPS, but also phospholipids. Phosphatidylinositol (PI), phosphatidylcholine, and a fluorescently labeled derivative of phosphatidylethanolamine (R-PE) are each transferred by LBP from membranes to HDL particles. The transfer could be observed using recombinant LBP and sCD14 or whole human plasma, and the plasma-mediated transfer of PI could be blocked by anti-LBP and partially inhibited by anti-CD14. sCD14 appears to act as a soluble shuttle for phospholipids since direct binding of PI and R-PE to sCD14 was observed and because addition of sCD14 accelerated transfer of these lipids. These studies define a new function for LBP and sCD14 and describe a novel mechanism for the transfer of phospholipids in blood. In further studies, we show evidence suggesting that LBP transfers LPS and phospholipids by reciprocal exchange: LBP-catalyzed binding of R-PE to LPS x sCD14 complexes was accompanied by the exit of LPS from sCD14, and LBP-catalyzed binding of R-PE to sCD14 was accelerated by prior binding of LPS to sCD14. Binding of one lipid is thus functionally coupled with the release of a second. These results suggest that LBP acts as a lipid exchange protein.
Similar articles
- Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.
Wurfel MM, Hailman E, Wright SD. Wurfel MM, et al. J Exp Med. 1995 May 1;181(5):1743-54. doi: 10.1084/jem.181.5.1743. J Exp Med. 1995. PMID: 7536794 Free PMC article. - Soluble CD14 mediates efflux of phospholipids from cells.
Sugiyama T, Wright SD. Sugiyama T, et al. J Immunol. 2001 Jan 15;166(2):826-31. doi: 10.4049/jimmunol.166.2.826. J Immunol. 2001. PMID: 11145656 - Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14.
Yu B, Wright SD. Yu B, et al. J Biol Chem. 1996 Feb 23;271(8):4100-5. doi: 10.1074/jbc.271.8.4100. J Biol Chem. 1996. PMID: 8626747 - Modulatory effects of sCD14 and LBP on LPS-host cell interactions.
Kitchens RL, Thompson PA. Kitchens RL, et al. J Endotoxin Res. 2005;11(4):225-9. doi: 10.1179/096805105X46565. J Endotoxin Res. 2005. PMID: 16176659 Review. - Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review.
Schumann RR. Schumann RR. Res Immunol. 1992 Jan;143(1):11-5. doi: 10.1016/0923-2494(92)80074-u. Res Immunol. 1992. PMID: 1373512 Review.
Cited by
- TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling.
Ciesielska A, Matyjek M, Kwiatkowska K. Ciesielska A, et al. Cell Mol Life Sci. 2021 Feb;78(4):1233-1261. doi: 10.1007/s00018-020-03656-y. Epub 2020 Oct 15. Cell Mol Life Sci. 2021. PMID: 33057840 Free PMC article. Review. - Serum soluble toll-like receptor 4 and risk for clinical severity in COVID-19 patients.
Houssen ME, Elmaria MO, Badr D, El-Mahdy R, Ghannam MA, El-Ashwah S, Denewer M, Mortada MI. Houssen ME, et al. Pneumonia (Nathan). 2024 Jan 5;16(1):1. doi: 10.1186/s41479-023-00121-9. Pneumonia (Nathan). 2024. PMID: 38178206 Free PMC article. - Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14.
Karhukorpi J, Yan Y, Niemela S, Valtonen J, Koistinen P, Joensuu T, Saikku P, Karttunen R. Karhukorpi J, et al. Clin Exp Immunol. 2002 May;128(2):326-32. doi: 10.1046/j.1365-2249.2002.01837.x. Clin Exp Immunol. 2002. PMID: 11985523 Free PMC article. - Nanocarriers' entry into the cell: relevance to drug delivery.
Hillaireau H, Couvreur P. Hillaireau H, et al. Cell Mol Life Sci. 2009 Sep;66(17):2873-96. doi: 10.1007/s00018-009-0053-z. Epub 2009 Jun 5. Cell Mol Life Sci. 2009. PMID: 19499185 Free PMC article. Review. - A novel ML protein from Manduca sexta may function as a key accessory protein for lipopolysaccharide signaling.
Ao JQ, Ling E, Rao XJ, Yu XQ. Ao JQ, et al. Mol Immunol. 2008 May;45(10):2772-81. doi: 10.1016/j.molimm.2008.02.006. Epub 2008 Mar 17. Mol Immunol. 2008. PMID: 18343500 Free PMC article.
References
- J Biol Chem. 1982 Apr 25;257(8):4535-40 - PubMed
- J Immunol. 1996 Nov 15;157(10):4648-56 - PubMed
- J Lipid Res. 1988 Dec;29(12):1593-602 - PubMed
- J Exp Med. 1989 May 1;169(5):1779-93 - PubMed
- Science. 1990 Sep 21;249(4975):1429-31 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous